Chemoprevention in prostate cancerPARNES, Howard L; FIGG, William D.Pharmacotherapy. 2006, Vol 26, Num 10, pp 1533-1533, issn 0277-0008, 1 p.Article

Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trialPINSKY, Paul F; PARNES, Howard L; ANDRIOLE, Gerald et al.BJU international (Papier). 2014, Vol 113, Num 2, pp 254-259, issn 1464-4096, 6 p.Article

Prevention of hormone-related cancers: Prostate CancerPARNES, Howard L; THOMPSON, Ian M; FORD, Leslie G et al.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 368-377, issn 0732-183X, 10 p.Article

Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention TrialKRISTAL, Alan R; TILL, Cathee; MINASIAN, Lori M et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 8, pp 1494-1504, issn 1055-9965, 11 p.Article

Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancerDAHUT, William L; MADAN, Ravi A; PARNES, Howard L et al.BJU international (Papier). 2013, Vol 111, Num 8, pp 1269-1280, issn 1464-4096, 12 p.Article

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers : The Selenium and Vitamin E Cancer Prevention Trial (SELECT)LIPPMAN, Scott M; KLEIN, Eric A; KELLOGG PARSONS, J et al.JAMA, the journal of the American Medical Association. 2009, Vol 301, Num 1, pp 39-51, issn 0098-7484, 13 p.Article

Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific BiomarkersANTONARAKIS, Emmanuel S; HEATH, Elisabeth I; BAKER, Sharyn D et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 4986-4993, issn 0732-183X, 8 p.Article

Does the Level of Prostate Cancer Risk Affect Cancer Prevention with Finasteride?THOMPSON, Ian M; TANGEN, Catherine M; PARNES, Howard L et al.Urology (Ridgewood, NJ). 2008, Vol 71, Num 5, pp 854-857, issn 0090-4295, 4 p.Article

Finasteride and high-grade prostate cancer in the prostate cancer prevention trialLUCIA, M. Scott; EPSTEIN, Jonathan I; KATTAN, Michael W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 18, pp 1375-1383, issn 0027-8874, 9 p.Article

Insulin-Like Growth Factors and Insulin-Like Growth Factor― Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialNEUHOUSER, Marian L; PLATZ, Elizabeth A; HOQUE, Ashraful et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 2, pp 91-99, issn 1940-6207, 9 p.Article

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)KLEIN, Eric A; THOMPSON, Ian M; KARP, Daniel D et al.JAMA, the journal of the American Medical Association. 2011, Vol 306, Num 14, pp 1549-1556, issn 0098-7484, 8 p.Article

A Phase I Clinical Study of High Dose Ketoconazole Plus Weekly Docetaxel for Metastatic Castration Resistant Prostate CancerFIGG, William D; WOO, Sukyung; GULLEY, James L et al.The Journal of urology. 2010, Vol 183, Num 6, pp 2219-2226, issn 0022-5347, 8 p.Article

Assessing prostate cancer risk : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 8, pp 529-534, issn 0027-8874, 6 p.Article

Effect of finasteride on the sensitivity of PSA for detecting prostate cancerTHOMPSON, Ian M; CHEN CHI; ANKERST, Donna Pauler et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 16, pp 1128-1133, issn 0027-8874, 6 p.Article

Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialGUREL, Bora; LUCIA, M. Scott; PESKOE, Sarah B et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 5, pp 847-856, issn 1055-9965, 10 p.Article

Long-Term Survival of Participants in the Prostate Cancer Prevention TrialTHOMPSON, Ian M; GOODMAN, Phyllis J; TANGEN, Catherine M et al.The New England journal of medicine. 2013, Vol 369, Num 7, pp 603-610, issn 0028-4793, 8 p.Article

Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialPLATZ, Elizabeth A; TILL, Cathee; GOODMAN, Phyllis J et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 11, pp 2807-2813, issn 1055-9965, 7 p.Article

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. DiscussionBASLER, Joseph W; PIAZZA, Gary A; DJAVAN, Bob et al.The Journal of urology. 2004, Vol 171, Num 2, pp S59-S63, issn 0022-5347, 2Conference Paper

Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer. DiscussionPLATZ, Elizabeth A; KRISTAL, Alan R; PARNES, Howard L et al.The Journal of urology. 2004, Vol 171, Num 2, pp S54-S58, issn 0022-5347, 2Conference Paper

Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECTTrialBRASKY, Theodore M; DARKE, Amy K; KLEIN, Eric A et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 15, pp 1132-1141, issn 0027-8874, 10 p.Article

Androgen Receptor CAG Repeat Length and Association With Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialPRICE, Douglas K; CHAU, Cindy H; REICHARDT, Juergen K. V et al.The Journal of urology. 2010, Vol 184, Num 6, pp 2297-2302, issn 0022-5347, 6 p.Article

Phase III Prevention Trial of Fenretinide in Patients with Resected Non : Muscle-Invasive Bladder Cancer. CommentaryMEYSKENS, Frank L; SABICHI, Anita L; PISTERS, Louis L et al.Clinical cancer research. 2008, Vol 14, Num 1, issn 1078-0432, 2-3, 224-229 [8 p.]Article

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lowerTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.JAMA, the journal of the American Medical Association. 2005, Vol 294, Num 1, pp 66-70, issn 0098-7484, 5 p.Article

Prostate cancer chemoprevention agent development: The national cancer institute, division of cancer prevention portfolio. DiscussionPARNES, Howard L; HOUSE, Margaret G; KAGAN, Jacob et al.The Journal of urology. 2004, Vol 171, Num 2, pp S68-S75, issn 0022-5347, 2Conference Paper

Selenium: Epidemiology and basic science. DiscussionKLEIN, Eric A; PIAZZA, Gary; KLEIN, Eric et al.The Journal of urology. 2004, Vol 171, Num 2, pp S50-S53, issn 0022-5347, 2Conference Paper